Abstracts

Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin

Thursday 16 October, 2025

Objectives: Tisotumab vedotin (TV), a tissue factor-directed antibody-drug conjugate (ADC), is approved in the United States at a dose of 2.0…

Read more

In silico trials platform for exploration of trial design space in atopic dermatitis

Thursday 16 October, 2025

Objectives: Atopic dermatitis (AD) clinical trials are stymied by a complex pathophysiology characterized by a wide spectrum of endotypes and…

Read more

Generation of a virtual population for a multi-strain model of natural and vaccinal immunization against influenza

Thursday 16 October, 2025

Objectives: The generation of a Virtual Population (VP) is the one of the last steps of a QSP model calibration…

Read more

Translational physiologically based pharmacokinetic modeling to predict human pulmonary kinetics after inhalation

Thursday 16 October, 2025

Objectives:  Oral inhalation is an attractive approach for drug delivery, especially when targeting respiratory diseases. Inhalation provides a rapid onset…

Read more

Automated QSP model order reduction combining multiple state-level reduction approaches

Thursday 16 October, 2025

Objectives: Quantitative systems pharmacology (QSP) models are useful tools for drug target identification and extrapolation. However, their large size can…

Read more

Model-based evaluation of predictive markers of response to adalimumab in juvenile idiopathic arthritis

Thursday 16 October, 2025

Introduction: Juvenile Idiopathic Arthritis (JIA) is a group of heterogeneous idiopathic inflammatory arthritis characterised by childhood-onset [1]. The ability of…

Read more

A model-based algorithm for mycophenolate dose adjustment in paediatric transplantation patients

Thursday 16 October, 2025

Introduction: The immunosuppressant effect of mycophenolate sodium is determined by mycophenolic acid (MPA), which is the active component released in…

Read more

Virtual population analysis of a Quantitative Systems Pharmacology (QSP) model of atopic dermatitis (AtD) to evaluate AtD treatments

Thursday 16 October, 2025

Introduction: Atopic dermatitis (AtD) is a chronic inflammatory skin condition characterized by eczematous lesions and intense itch [1]. The exact cause…

Read more

Human effective dose prediction of analgesic drug using translational PK-PD modeling

Thursday 16 October, 2025

Objective: Translational PK–PD modeling is aimed to predict exposure-response relationships in human based on preclinical data[1]. As such translational research…

Read more

Model informed dosage regimen optimization of anti-CD47 antibody using target-mediated drug disposition model.

Thursday 16 October, 2025

Objectives:  Target-mediated drug disposition (TMDD) model is used to describe a nonlinear pharmacokinetics (PK) phenomenon that is caused by high-affinity…

Read more